Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Cost efficiency of targeted therapy

Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy
Cost efficiency of targeted therapy ( Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy )
17 Jul 2012

Society and money - the cancer conundrum

Prof Richard Sullivan – Kings College, London, UK
Society and money - the cancer conundrum ( Prof Richard Sullivan – Kings College, London, UK )
17 Jul 2012

Translating cancer research to personalised treatment: Can it work?

Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Translating cancer research to personalised treatment: Can it work? ( Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
17 Jul 2012

Highlights of the 22nd EACR meeting and tackling glioblastoma

Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012

Adjuvant cetuximab disappoints again in mCRC

Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
Adjuvant cetuximab disappoints again in mCRC ( Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France )
16 Jul 2012

The WINTHER study

Prof Razelle Kurzrock - MD Anderson Cancer Center, Houston, USA
The WINTHER study ( Prof Razelle Kurzrock - MD Anderson Cancer Center, Houston, USA )
16 Jul 2012

Use of electronic data to raise the standard of cancer care

Brett Davis – Oracle Corporation, USA
Use of electronic data to raise the standard of cancer care  ( Brett Davis – Oracle Corporation, USA )
16 Jul 2012

Drugging the cancer genome: opportunities and challenges

Prof Paul Workman - Institute of Cancer Research, UK
Drugging the cancer genome: opportunities and challenges ( Prof Paul Workman - Institute of Cancer Research, UK )
16 Jul 2012

A new direction for development of targeted cancer therapies

Dr Edison Liu – Jackson Laboratory, USA
A new direction for development of targeted cancer therapies ( Dr Edison Liu – Jackson Laboratory, USA )
16 Jul 2012

Vandetanib increases progression free survival in medullary thyroid carcinoma

Dr Nick Botwood - AstraZeneca, UK
Vandetanib increases progression free survival in medullary thyroid carcinoma  ( Dr Nick Botwood - AstraZeneca, UK )
13 Jul 2012

WINTHER: The WIN therapeutics clinical trial

Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
WINTHER: The WIN therapeutics clinical trial ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
13 Jul 2012

Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012

Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands,
Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012 ( Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands, )
13 Jul 2012